Recent studies have shown a significant level of T cell immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in convalescent coronavirus disease 2019 (COVID-19) patients and unexposed healthy individuals. Also, SARS-CoV-2-reactive T memory cells occur in unexposed healthy individuals from endemic coronaviruses that cause the 'common cold.' The finding of the expression of adaptive SARS-CoV-2-reactive T memory cells in unexposed healthy individuals may be due to multiple cross-reactive viral protein targets following previous exposure to endemic human coronavirus infections. The opinion of the authors is that determination of protein sequence homologies across seemingly disparate viral protein libraries may provide epitope-matching data that link SARS-CoV-2-reactive T memory cell signatures to prior administration of cross-reacting vaccines to common viral pathogens. Exposure to SARS-CoV-2 initiates diverse cellular immune responses, including the associated 'cytokine storm'. Therefore, it is possible that the intact virus possesses a required degree of conformational matching, or stereoselectivity, to effectively target its receptor on multiple cell types. Therefore, conformational matching may be viewed as an evolving mechanism of viral infection and viral replication by an evolutionary modification of the angiotensin-converting enzyme 2 (ACE2) receptor required for SARS-CoV-2 binding and host cell entry. The authors propose that convalescent memory T cell immunity in individuals with mild or asymptomatic SARS-CoV-2 infection may result from an evolutionarily adapted immune response to coronavirus and the 'common cold'.

Center for Cognitive and Molecular Neuroscience 1st Faculty of Medicine Charles University Prague Prague Czech Republic

International Scientific Information Inc Melville NY USA

Zobrazit více v PubMed

Braun J, Loyal L, Frentsch M, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270–74. PubMed

Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489–501.e1415. PubMed PMC

Mateus J, Grifoni A, Tarke A, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89–94. PubMed PMC

Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T cell immunity in convalescent individuals with asymptomatic or Mild COVID-19. Cell. 2020;183:158–68.e114. PubMed PMC

Pawlowski C, Puranik A, Bandi H, et al. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. medRxiv. 2020;2020 20161976. PubMed PMC

Stefano GB. Conformational matching: A possible evolutionary force in the evolvement of signal systems. In: Stefano GB, editor. CRC Handbook of Comparative Opioid and Related Neuropeptide Mechanisms. Boca Raton: CRC Press Inc.; 1986. pp. 271–77.

Stefano GB. The evolvement of signal systems: Conformational matching a determining force stabilizing families of signal molecules. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1988;90:287–94. PubMed

Stefano ML, Kream RM, Stefano GB. A novel vaccine employing non-replicating rabies virus expressing chimeric SARS-CoV-2 spike protein domains: Functional inhibition of viral/nicotinic acetylcholine receptor complexes. Med Sci Monit. 2020;26:e926016. PubMed PMC

Braun M, Sharon E, Unterman I, et al. ACE2 Co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic. iScience. 2020;23:101384. PubMed PMC

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19